The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 10.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 7.00 (70.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 13.50
HYG Live PriceLast checked at -
Seneca Growth Capital VCT is an Investment Trust

To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update for the quarter ended 30 September 2018

23 Nov 2018 07:00

RNS Number : 2789I
Seneca Growth Capital VCT PLC
23 November 2018
 

Seneca Growth Capital VCT Plc (the "Company")

Update for the quarter ended 30 September 2018

The Company presents its quarterly update for the period from 1 July 2018 to 30 September 2018.

The Directors have recently reviewed the valuation of its portfolio as at the quarter ended 30 September 2018.

The unaudited net asset value per share ("NAV") of an Ordinary Share as at 30 September 2018 was 60.4p. This is a decrease of 1.9p from the previously published NAV for the period ended 30 June 2018, due to changes in the value of the quoted investments. No changes have been made to the unquoted valuations. The ordinary running costs of the Company (limited by the Cost Cap) have been absorbed by the New "B" Share class as set out in the prospectus for the current offer for subscription for those shares (the "Prospectus").

The unaudited NAV of a New "B" Share as at 30 September 2018 was 99.7p. This is a decrease of 0.3p from the initial offer price of 100p, due to running costs incurred in the quarter. The decrease is limited by the impact of the Cost Cap which restricts the burden of ordinary running costs on the New "B" Share class to 3% of the NAV of the New "B" Shares on an annualised basis ("the Cost Cap").

On 23 August 2018 and 27 September 2018, the Company made two allotments, issuing a total of 3,461,786 New "B" Shares. In accordance with the allotment formula set out in the Prospectus, the offer prices at which the New "B" Shares were issued were in the range of 100p to 105.8p per share.

Following the initial allotment on 23 August 2018, the Company repaid its £200,000 bank loan with RBS and the debenture in relation to the loan has now been released. The payment created an inter share class balance between the Ordinary Shares and the New "B" Shares which will be repaid from the next realisations from the Ordinary Share investments.

James Cowper Kreston, our auditors for the last 8 years, have decided to withdraw from auditing Public Interest Entities for the time being due to the increasing regulatory landscape and associated costs. Unfortunately this includes VCTs. The Board would like to thank them for all their support and constructive feedback during their period in office. The Company has therefore carried out a tender process, and the Board, on the recommendation of the Audit Committee, has agreed to appoint UHY Hacker Young LLP ("UHY") to fill the casual vacancy that has arisen. UHY will audit the Company's 2018 annual results for the year ending 31 December 2018, and shareholders will be asked to reappoint them at next year's AGM for the following year's audit.

The Directors are not aware of any other events or transactions which have taken place between 1 October 2018 and the publication of this statement which have had a material effect on the financial position of the Company.

Furthermore, for the purposes of DTR 5.6.1 of the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rules, the total number of shares in the Company in issue as at close of business on 1 October 2018 was 8,115,376 Ordinary Shares and 3,461,786 New "B" Shares each with a nominal value of 1p each. The Company does not hold any Ordinary Shares nor New "B" Shares in treasury. Therefore, the total number of voting rights in the Company is 11,577,162 (the 'Figure').The Figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's shares under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

 

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.com

 

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk

 

Any enquiries regarding the offer for subscription of New "B" Shares should be directed to:

 

John Davies at Seneca Partners Limited on 01942 295 981 or at John.Davies@senecapartners.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDVLLFLVFFLFBB
Date   Source Headline
19th May 20099:42 amRNSIssue of Equity
15th May 20093:27 pmRNSIssue of Equity
12th May 20097:00 amRNSInterim Management Statement
6th May 20097:00 amRNSResults of AGM and Issue of Equity
30th Apr 20097:00 amRNSTotal Voting Rights
16th Apr 20097:00 amRNSAvailability of Annual Accounts and Offer Letter
9th Apr 20091:04 pmRNSIssue of Equity-Replacement
9th Apr 200912:41 pmRNSIssue of Equity
9th Apr 200912:39 pmRNSOffer to Shareholders
6th Apr 20094:32 pmRNSDirector's Dealings
2nd Apr 20097:00 amRNSAnnual Report & Accounts and Notice of AGM
19th Nov 20089:54 amRNSDirector's Dealings
14th Nov 20081:08 pmRNSInterim Management Statement
28th Aug 20087:00 amRNSInterim Results
1st Aug 20084:00 pmRNSIssue of Equity
22nd Jul 20083:11 pmRNSResult of AGM
30th May 20083:25 pmRNSIssue of Equity
15th May 20087:00 amRNSInterim Management Statement
1st May 200810:55 amRNSIssue of Equity
8th Apr 20085:18 pmRNSAnnual Information Update
3rd Apr 20083:42 pmRNSIssue of Equity
19th Mar 20085:02 pmRNSOffer to shareholders
19th Mar 20085:02 pmRNSAnnual Report and Accounts
14th Jan 20085:22 pmRNSUpdate letter to Shareholders
3rd Jul 20063:56 pmRNSCompany Secretary Change
10th May 20062:49 pmRNSPurchase of Own Securities
26th Apr 20062:50 pmRNSChange of Name
25th Apr 20065:02 pmRNSDirector's Shareholding
20th Apr 20067:01 amRNSBVCT Update
20th Apr 20067:00 amRNSResult of AGM
10th Apr 20063:23 pmRNSDirector/PDMR Shareholding
3rd Apr 20064:28 pmRNSDirector's Shareholding
29th Mar 20061:09 pmRNSAnnual Information Update
24th Mar 20064:19 pmRNSFinal Results
9th Mar 20067:00 amRNSInvestment Process & Strategy
11th Nov 20054:33 pmRNSDirectorate Change
4th Nov 20054:04 pmRNSResult of AGM
3rd Oct 200511:19 amRNSNotice of AGM
27th Sep 20057:00 amRNSInterim Results
1st Sep 20058:31 amRNSBoard Changes
16th Aug 20055:51 pmRNSVCT Status
16th Aug 20059:09 amRNSVCT Status
2nd Aug 200510:56 amRNSBoard Change
12th Jul 20055:04 pmRNSBoard Changes
29th Apr 200510:22 amRNSFinal Results
14th Feb 20054:02 pmRNSIssue of Equity
9th Feb 20052:20 pmRNSCancellation of Listing
8th Feb 200511:27 amRNSCancellation of Listing
28th Jan 20052:55 pmRNSIssue of Equity
14th Jan 20053:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.